![Helga Zharov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helga Zharov
Conseiller Juridique Général chez
ALVOTECH
Fortune : - $ au 31/08/2026
Profil
Helga Tatjana Zharov is currently Deputy Chief Executive Officer at Alvotech hf since 2020.
Also holds director positions at Reykjavik University, Skólavegur ehf, and Talna ehf.
Since 2023, serves as Secretary & General Counsel at Alvotech.
Formerly Deputy Chief Executive Officer at deCODE Genetics ehf from 2016 to 2020.
Served as Secretary & Vice President-Administration at deCODE genetics, Inc. from 1999 to 2007 and Secretary & Vice President-Corporate Governance at deCODE Genetics ehf from 2003 to 2007.
Worked as MD-Legal, General Counsel & Compliance Officer at Virding hf from 2008 to 2015 and General Counsel at Auður Capital hf during the same period.
Held director roles at ORF Genetics, Sýn hf (Independent Director), CRI hf., and Íslandsbanki hf.
Partner & Tax Attorney at PricewaterhouseCoopers hf.
Education includes graduate degree from the University of Iceland.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALVOTECH -.--% | 06/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Helga Zharov
| Sociétés | Poste | Début |
|---|---|---|
| ALVOTECH | Conseiller Juridique Général | 01/01/2023 |
Talna ehf | Directeur/Membre du Conseil | - |
Skólavegur ehf | Directeur/Membre du Conseil | - |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/05/2020 |
Reykjavik University
 Reykjavik University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Anciens postes connus de Helga Zharov
| Sociétés | Poste | Fin |
|---|---|---|
deCODE Genetics ehf
 deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology and genomics research company focused on analyzing and understanding the human genome | Corporate Officer/Principal | 01/01/2020 |
Virding hf
 Virding hf Investment ManagersFinance Provides financial services | Compliance Officer | 01/01/2015 |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology and genomics research company focused on analyzing and understanding the human genome | Directeur Administratif | 01/12/2007 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Directeur Administratif | - |
| ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Helga Zharov
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Health Technology |
ORF Genetics
 ORF Genetics BiotechnologyHealth Technology Manufactures cytokines products | Health Technology |
University of Iceland
 University of Iceland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers hf
 PricewaterhouseCoopers hf Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers hf is a company based in Iceland, Iceland. | Commercial Services |
Virding hf
Virding hf Investment ManagersFinance Provides financial services | Finance |
Sýn hf
 Sýn hf Major TelecommunicationsCommunications Offers telecommunication products and services | Communications |
Íslandsbanki hf
 Íslandsbanki hf Regional BanksFinance Provides banking and financial services | Finance |
Auður Capital hf
 Auður Capital hf Investment ManagersFinance Audur Capital is an Alternative Investment management firm. It invests primarily in established profitable businesses owned and operated by women, which produce and sell products or services intended for women. The fund seeks companies with growth potential and strong management teams. Its investment strategy involves companies with a long operating history (minimum 3-5 years), strong cash-flows and a solid market position. Audur Capital was established in 2007 and merged with Virdiong in January 2014. | Finance |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology and genomics research company focused on analyzing and understanding the human genome | Commercial Services |
CRI hf.
 CRI hf. Chemicals: SpecialtyProcess Industries Designs, licenses and sells emissions-to-liquids (ETL) process technology for producing green methanol | Process Industries |
Reykjavik University
Reykjavik University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Skólavegur ehf | |
Talna ehf | |
Alvotech
 Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
